Aarhus University

Running trials

• Not yet recruiting

  Oral Galactose as a Substrate for Post-Exercise Skeletal Muscle Glycogen Repletion in Individuals With Type 1 Diabetes

  NCT07774780· Source

• Not yet recruiting

  Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?

  2026-525513-31-00· Phase 3· Source

• Not yet recruiting

  Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to Improve Fatigue, Pain, and Quality of Life by Targeting Mitochondrial Dysfunction and Autonomic Nervous System Impairment

  NCT07317401· Source

• Not yet recruiting

  A randomized placebo-controlled double-blind trial phase II two-arm study to investigate infarct growth over 72 hours assessed with diffusion weighted imaging on MRI after treatment with intravenous tocilizumab or placebo in patients above 18 years of age with acute ischemic stroke undergoing endovascular thrombectomy.

  2025-521269-28-00· Phase 2· Source

• Recruiting

  EXpain Trial - Exercise an a Non-pharmacological Pain-relieving Treatment in People With Multiple Sclerosis

  NCT07342777· Source

• Recruiting

  A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

  NCT06847542· Phase 3· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV)

  2024-516652-18-00· Phase 3· Source

• Not yet recruiting

  Semaglutide Treatment in Type 1 Diabetes

  NCT06909006· Phase 3· Source

• Recruiting

  Prevention of Preeclampsia in Denmark: A National Implementation Study

  NCT07485140· Source

• Recruiting

  FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer

  NCT06877949· Phase 3· Source

• Recruiting

  The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease

  NCT06707402· Source

• Active, not recruiting

  HOPE in Diabetic Kidney Disease (HyperpOlarised PyruvatE in Diabetic Kidney Disease)

  2023-508824-36-00· Phase 2· Source

• Enrolling by invitation

  Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System

  NCT06745011· Source

• Recruiting

  Chronic kidney disease – imaging the metabolic derangements with ultra-sensitive MRI

  2024-512491-35-00· Phase 2· Source

• Recruiting

  IMPROCAS - Improved Prediction of Ovarian Cancer Surgery

  2023-503398-39-00· Phase 2· Source

• Enrolling by invitation

  Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme

  NCT05908669· Source

• Recruiting

  INVITED trial

  2022-500906-17-01· Phase 2· Source

• Recruiting

  Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

  NCT05327894· Phase 3· Source

• Recruiting

  Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling

  NCT05431257· Phase 2· Source

• Recruiting

  A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

  NCT04319367· Phase 2· Source

• Active, not recruiting

  A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  NCT04408638· Phase 3· Source

• Active, not recruiting

  Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

  NCT04623541· Phase 1/2· Source

• Recruiting

  MRI of Neurometabolic Impairment in ALS and TIA Using Hyperpolarized Pyruvate

  2024-516954-24-00· Phase 2· Source

• Recruiting

  MRI with hyperpolarized pyruvate in gliblastoma - a phase II study

  2024-515408-37-00· Phase 2· Source

• Active, not recruiting

  Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

  NCT03772028· Phase 3· Source

• Recruiting

  SIOP RANDOMET 2017

  2023-508926-91-00· Phase 3· Source

• Active, not recruiting

  Efficacy Study of Nivolumab Compared to Placebo in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIB/C Melanoma (CheckMate 76K)

  2022-502354-14-00· Phase 3· Source

• Completed

  Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis

  NCT03831776· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 1 diabetes3 recruiting
• Childhood cancers2 recruiting
• Glioblastoma2 recruiting
• Parkinson disease2 recruiting
• Stroke2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• Familial hypercholesterolaemia1 recruiting
• HIV1 recruiting
• Lewy body dementia1 recruiting
• Long COVID and ME/CFS1 recruiting
• Lung cancer1 recruiting
• Macular degeneration1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple sclerosis1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Polycystic kidney disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  ARETHA: cARdiomems vEriciguaT Heart fAilure (A double-blind randomized placebo-controlled trial of vericiguat in heart failure patients with CardioMEMS™ HF System)

  2024-514111-10-00· Phase 4· Source

• Completed

  The Effects of Combined Energy and Carbohydrate Restriction on Exercise Capacity

  NCT06381908· Source

• Completed

  Phase II, multi‑cohort trial of neoadjuvant and post‑surgery IO102‑IO103 and pembrolizumab in patients with selected resectable tumors

  2022-502787-20-00· Phase 2· Source

• Completed

  Trial of Four Spinal Cord Stimulation Paradigms for Gait Impairment in Parkinson's Disease

  NCT07659405· Source

• Completed

  Engaging Parents in Neuropsychological Rehabilitation for Childhood Cancer Survivors: The ImPACT Program - A Pilot Study

  NCT05483166· Source

• Completed

  Spinal Cord sTimulation thEraPy for Parkinson's Disease Patients With Gait Problems

  NCT05110053· Source

• Completed

  Exercise Booster Sessions in People With Multiple Sclerosis

  NCT04913012· Source

• Completed

  Breakfast for Young Women

  NCT04652713· Source

• Withdrawn

  Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

  NCT05867056· Phase 1· Source

• Completed

  Novel Organic Kale Products for Prevention of Obesity/Type 2 Diabetes

  NCT04298970· Source

• Recruiting

  Melanoma Metastasized to the Brain and Steroids

  NCT03563729· Phase 2· Source

Trial sites

• Aarhus Universitet2 trials
• Aarhus University9 trials
• Aarhus University, Department for Public Health, Section for Sport Science1 trial
• Institute of Clinical Medicine, Aarhus University1 trial
• Aarhus University1 trial
• Aarhus University, Department of Public Health, Sport Science1 trial
• Section for Sport Science, Department of Public Health, Aarhus University1 trial
• Aarhus Universitet19 trials
• Aarhus University4 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Parkinson disease116 works · 4 trials
• Obesity106 works · 5 trials
• Type 2 diabetes102 works · 1 trials
• Schizophrenia78 works · 0 trials
• Multiple sclerosis64 works · 2 trials
• Bipolar disorder64 works · 0 trials
• Chronic kidney disease60 works · 1 trials
• Coronary artery disease40 works · 0 trials
• Type 1 diabetes38 works · 3 trials
• Depression37 works · 0 trials
• Bladder cancer36 works · 0 trials
• Rheumatoid arthritis30 works · 0 trials
• Autism29 works · 0 trials
• Osteoporosis26 works · 0 trials
• Cervical cancer23 works · 0 trials
• Lupus (SLE)18 works · 0 trials
• Systemic sclerosis (scleroderma)14 works · 0 trials
• Head and neck cancer13 works · 1 trials
• Idiopathic pulmonary fibrosis12 works · 0 trials
• Endometriosis12 works · 0 trials
• Psoriatic arthritis10 works · 0 trials
• Diffuse large B-cell lymphoma9 works · 1 trials
• Ankylosing spondylitis9 works · 0 trials
• Lewy body dementia7 works · 1 trials
• High blood pressure6 works · 0 trials